Chandan Healthcare Ltd
Chandan Healthcare Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Chandan Healthcare Limited expects top-line growth much higher than 30% in the next financial year (FY’27), surpassing current projections. The company expects revenue growth significantly higher than 30% in FY'27, surpassing previous projections.
From Chandan Healthcare Ltd's Q3 FY26 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Chandan Healthcare Limited expects top-line growth much higher than 30% in the next financial year (FY’27), surpassing current projections.
- New government contracts, including a INR55 crore per year project in Punjab and Guwahati, will act as significant growth drivers.
- Expansion plans include launching 18 new labs and 37 comprehensive centers in the current year, with further scale-up in the next two to three years.
- The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion.
- A strategic focus on Tier 2, 3, and 4 cities, which contribute 90% of the business, will support volume growth.
2 more points from Chandan Healthcare Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Chandan Healthcare Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Planned investment of INR 100 crores over the next three years for setting up 100 new laboratories.
- Each laboratory requires approximately INR 1 crore in capex (INR 50-75 lakhs for setup plus INR 50 lakhs for machines).
- Preferential shares of INR 104 crores have been raised, with INR 26 crores already received, to fund expansion smoothly.
- Expansion plan includes launching 13 new labs, 3 comprehensive centres, a PET scan facility at Gorakhpur, and a genome lab at Lucknow in the coming year.
- Central lab and wellness centre to begin in H1 FY27 at Jankipuram, Lucknow, expected to be the largest lab in Uttar Pradesh.
2 more points from Chandan Healthcare Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Chandan Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Chandan Healthcare Limited has secured significant government contracts, including a major contract from Punjab and Guwahati, valued at approximately INR 55 crores annually.
- The company has a fully subscribed preferential shares issuance of INR 104 crores, of which INR 26 crores (25%) has been received, with the balance expected within the next year to fund expansion plans.
- Expansion plans include launching 18 new labs and 7 comprehensive centers this year, with an additional 13 labs and 3 comprehensive centers planned next year.
2 more points from Chandan Healthcare Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Chandan Healthcare Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹65 Cr, net profit ₹5 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Chandan Healthcare Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Vijaya Diagnostic Centre Ltd (Q3 FY26)
FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnost.'s Q3 FY26 earnings call — and…
- Rainbow Childrens Medicare Ltd (Q3 FY26)
Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…
- Krsnaa Diagnostics Ltd (Q3 FY26)
Retail segment showing strong momentum, with retail revenue growing nearly 8x YoY in Q3 FY '26, contributing 8% of total revenue; network expanded to over…
- Park Medi World Ltd (Q3 FY26)
FY26 capex of ~INR 280 crores for Agra and Panchkula units; FY27 capex primarily for Kanpur and Delhi (~INR 110 crores). Key concall takeaways from Park Medi…
Arthneeti Pro · Annual
Chandan Healthcare Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Chandan Healthcare Ltd Q3 FY26 results?
Chandan Healthcare Limited expects top-line growth much higher than 30% in the next financial year (FY’27), surpassing current projections. The company expects revenue growth significantly higher than 30% in FY'27, surpassing previous projections.
What is Chandan Healthcare Ltd share price analysis?
Chandan Healthcare Ltd currently shows a neutral. The stock trades at a P/E of 23.1 with a market cap of ₹606 Cr. Investors should review the full earnings analysis for detailed insights.
Is Chandan Healthcare Ltd planning capital expenditure?
Planned investment of INR 100 crores over the next three years for setting up 100 new laboratories.
Keep Chandan Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.